Regular Article
Alterations in Hypothalamic–Pituitary–Adrenal Function Correlated with the Onset of Murine SLE in MRL +/+ and lpr/lpr Mice

https://doi.org/10.1006/brbi.1998.0535Get rights and content

Abstract

Systemic lupus erythematosus (SLE) is a spontaneously occurring, chronic autoimmune disease that can manifest neuropsychiatric abnormalities. The pathways mediating these central changes are not known; however, neuroendocrine alterations associated with inflammation may play a role. Predisposition to and progression of autoimmune disease has been associated with altered hypothalamic–pituitary–adrenal (HPA) function and inflammation has been reported to alter hypothalamic regulation of HPA responses. We investigated whether disease progression in a murine model of systemic lupus erythematosus (MRL +/+. MRL lpr/lpr) resulted in altered expression of HPA regulatory peptides at the level of the hypothalamus and how these alterations related to circulating levels of corticosterone, corticosterone binding globulin, and autoantibody titers. We report that as MRL +/+ and MRL lpr/lpr mice age and circulating levels of autoantibodies increase, there is a decrease in hypothalamic CRH mRNA expression and finally an increase in AVP mRNA expression. We also report that associated with increased autoantibody levels, disease progression, and altered hypothalamic peptide expression there is an increase in circulating levels of corticosterone and a trend for levels of corticosterone binding globulin to decrease. Our data complement previous observations of altered peptidergic regulation of the HPA axis and increased HPA activity during chronic inflammation in exogenously induced rodent models of chronic inflammation and indicate that similar processes may occur in spontaneous murine models of SLE.

References (39)

  • D.V. Vlahakos et al.

    Anti-DNA antibodies form immune deposits at distinct glomerular and vascular sites

    Kidney Int.

    (1992)
  • D.D. Bloom et al.

    Overlap of the anti-Sm and anti-DNA responses of MRL/Mp-lpr/lpr mice

    J. Immunol.

    (1993)
  • V.M. Chesnokova et al.

    Patterns of interaction between the immune and endocrine systems in the manifestation of hereditary autoimmune disorders in NZB mice

    Bull. Exp. Biol. Med.

    (1995)
  • H.S. Chowdrey et al.

    Evidence for arginine-vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis

    Br. J. Pharmacol.

    (1995)
  • H.S. Chowdrey et al.

    Endogenous substance-P inhibits the depression of corticotropin-releasing-hormone during a chronic inflammatory stress

    Life Sci.

    (1995)
  • M.S. Harbuz et al.

    Role of central catecholamines in the modulation of corticotropin-releasing factor messenger-RNA during adjuvant-induced arthritis in the rat

    Br. J. Rheumatol.

    (1994)
  • M.S. Harbuz et al.

    Evidence for altered hypothalamic CRF in immune-mediated diseases

    Ann. N.Y. Acad. Sci.

    (1995)
  • M.S. Harbuz et al.

    Stress and the hypothalamo–pituitary–adrenal axis: Acute, chronic and immunological activation

    J. Endocrinol.

    (1992)
  • M.S. Harbuz et al.

    The role of endogenous serotonin in adjuvant-induced arthritis in the rat

    Br. J. Rheumatol.

    (1996)
  • Cited by (37)

    • Neuropsychiatric systemic lupus erythematosus and cognitive dysfunction: The MRL-lpr mouse strain as a model

      2014, Autoimmunity Reviews
      Citation Excerpt :

      The stress-induced increase serum concentration of glucocorticoids is essential for the prevention of autoreactive or uncontrolled amplification of the immune response, which results in autoimmunity and self-injury. A defective HPA axis may then confer susceptibility to autoimmune disorders, and it seems that such a deficiency is present in both murine and human lupus [110,164,168]. Nowadays, studies on the function of the HPA axis are rather limited in patients with SLE and often confounded by the effect of concomitant glucocorticoid treatment.

    • Altered neuroendocrine status at the onset of CNS lupus-like disease

      2013, Brain, Behavior, and Immunity
      Citation Excerpt :

      Although far from being elucidated, the key point in understanding a dysfunctional HPA axis could lie in significant structural and functional changes in the PVN, the key interface structure between the nervous and endocrine systems. We and others have previously reported upregulated arginine-vasopressin signal expression, as well as enhanced Ki67, Fluoro Jade B and H&E staining in the PVN of diseased MRL/lpr mice (Sakic et al., 1999; Shanks et al., 1999; Ballok et al., 2003a,b; Stanojcic et al., 2009, 2010). More recently, a similar discrepancy in PVN H&E staining was observed when 17-week old 485 mice were compared to age-matched 6825 mice (Loheswaran et al., 2010).

    • Disturbed distribution of proliferative brain cells during lupus-like disease

      2009, Brain, Behavior, and Immunity
      Citation Excerpt :

      Similarly, a group of PVN parvocellular neurons co-secrete AVP and CRH into the anterior pituitary by projecting through the ME (Kupfermann, 1991). Consistent with the above, imbalanced AVP/CRH mRNA expression ratio in the PVN (Sakic et al., 1999; Shanks et al., 1999) and disturbed activity of the hypothalamus–pituitary-adrenal axis are reported in MRL/lpr mice (Hu et al., 1993; Lechner et al., 1996; Lechner et al., 2000). The role of Ki67+/BrdU− neurons in the PVN and AVP overexpression may be of particular importance in understanding the etiology of endocrine and behavioral deficits in the MRL model and SLE patients.

    • Purine receptor antagonist modulates serology and affective behaviors in lupus-prone mice: Evidence of autoimmune-induced pain?

      2008, Brain, Behavior, and Immunity
      Citation Excerpt :

      When considering that suramin does not significantly cross the BBB or the blood–CSF barrier (Sanderson et al., 2007), and that neuronal atrophy did not arise in drug treated MRL +/+ animals, it was unlikely that dendritic aberrations in the hippocampus of MRL-lpr animals were a by-product of treatment. Since chronic administration of corticosterone in drinking water, however, severely deteriorated neuronal morphology of asymptomatic animals, CA1 atrophy may be induced by an autoimmunity-sustained upregulation of corticosterone production in MRL-lpr animals (Shanks et al., 1999). Given that a low-calorie diet completely prevents splenomegaly and autoimmunity in MRL-lpr animals (Fernandes and Good, 1984), inborn errors in metabolism appear to underlie the dysregulation of neuro-immuno-endocrine networks that manifest disease.

    • Chapter 9 Adrenal Involvement in Systemic Autoimmune Diseases

      2008, Handbook of Systemic Autoimmune Diseases
      Citation Excerpt :

      A significantly lower increase in plasma corticosteroid concentrations after stimulation with recombinant IL-1 has been demonstrated in the MRL/lpr murine model of lupus (Lechner et al., 2000). In addition, aging of mice, which is accompanied by increased autoantibody production, is associated with a decrease in hypothalamic expression of the CRH-mRNA (Shanks et al., 1999). Studies of the HPA axis in patients with SLE are limited and often influenced by concomitant glucocorticoid treatment.

    View all citing articles on Scopus
    View full text